MKI67 and melanoma: Recent studies showed that exosomes derived from human melanoma and NSCLC significantly reduced the Ki-67 expression of T cells and CD8+ T cells, which is restored in the presence anti-PD-1 blocking antibodies (Chen G. et al., 2018; Cordonnier et al., 2020).